Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1999
09/21/1999US5955574 Analogs of parathyroid hormone
09/21/1999US5955573 Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
09/21/1999US5955572 Structural mimics of RGD-binding sites
09/21/1999US5955571 Novel n-branched nucleic acids with non-ribose phosphate backbone; for use in controlling gene expression, antisense agents, viricides, diagnosis, and genetic engineering techniques
09/21/1999US5955508 Method for the enhancement of lymphocyte activity against opportunistic microbial pathogens
09/21/1999US5955503 Modified amino acid compounds useful as carriers in the delivery of biologically active agents such as, for example, bioactive peptides and the like
09/21/1999US5955491 Method for treating osteoporosis
09/21/1999US5955450 Peritoneal dialysis solutions and methods usable to minimize the injury and adverse physiological effects caused by peritonitis
09/21/1999US5955449 Diagnosis and treatment of bacterial dysentery
09/21/1999US5955448 Method for stabilization of biological substances during drying and subsequent storage and compositions thereof
09/21/1999US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are
09/21/1999US5955442 Methods for treating respiratory disease
09/21/1999US5955441 Genetic inhibition of complement mediated inflammatory response
09/21/1999US5955436 Topically administering to corneal wounds
09/21/1999US5955433 Method of thrombin inhibition
09/21/1999US5955432 Stimulants for hematopoiesis, protection of cells from radiation
09/21/1999US5955431 Mast cell protease peptide inhibitors
09/21/1999US5955430 Use of angiotensin II fragments and analogs thereof in tissue repair
09/21/1999US5955429 Human apoptosis-associated protein
09/21/1999US5955428 DNA encoding human metallothionein
09/21/1999US5955427 Pharmaceutical composition
09/21/1999US5955426 Such peptides radiolabeled with a radiosiotope, as well as methods for using such peptides for radiodiagnostic and radiotherapeutic purposes
09/21/1999US5955425 Parathyroid hormone analogues for the treatment of osteoporosis
09/21/1999US5955424 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs
09/21/1999US5955422 Production of erthropoietin
09/21/1999US5955421 Peptides containing D-2-alkyl-Tryptophan
09/21/1999US5955420 Exposing cell comprising rse receptor to exogenous growth arrest-specific gene 6 (gas6) polypeptide to activate receptor; treating neurologic disorders
09/21/1999US5955366 Polynucleotides encoding cytokine suppressive anti-inflammatory drug binding proteins
09/21/1999US5955365 Introducing polynucleotides into cells
09/21/1999US5955364 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
09/21/1999US5955355 Chromosome 18 marker
09/21/1999US5955354 RAS P21-interacting protein (RGL) and its RAS interacting domain (RID)
09/21/1999US5955346 Variants of human prolactin and human placeatal lactogen
09/21/1999US5955345 Nucleic acids encoding pancreatic islet cell antigens obtained by molecular cloning
09/21/1999US5955339 Human inositol monophosphatase H1
09/21/1999US5955338 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase
09/21/1999US5955337 Lyase enzyme which can be used to screen fungicidal compounds
09/21/1999US5955317 Antibodies to β-amyloids or their derivatives and use thereof
09/21/1999US5955316 Recombinant expression plasmid vector for efficient and commerical production includes promoter, signal sequence, and nucleotide sequences of amino-terminus of endogenous aspergillus polypeptide, peptide linker and lactoferrin
09/21/1999US5955315 Nucleic acids encoding human interleukin-4
09/21/1999US5955314 Nucleotide sequence that codes polypeptide controller of g-protein signaling; prevention and diagnosis of cancer; anticarcinogenic agents; antiinflammatory agents; therapy of nervous system disorders; antisense agents
09/21/1999US5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof
09/21/1999US5955312 For diagnosis of proliferative disorders; antiproliferative agents; antisense agents
09/21/1999US5955311 Monoclonal antibodies specific to VEGF receptors and uses thereof
09/21/1999US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62)
09/21/1999US5955308 cDNA clone HEAOD54 that encodes a human 7-transmembrane receptor
09/21/1999US5955306 Nucleotide sequences that codes for a polypeptide that is useful in the development of screening methods, therapeutics and diagnostic tools related to obesity
09/21/1999US5955305 Human retinoid binding protein
09/21/1999US5955304 DivIB
09/21/1999US5955303 Human chemokine receptor-like protein
09/21/1999US5955302 Polynucleotide sequence encoding human dosage compensation-associated protein
09/21/1999US5955301 Diagonosis, prevention and therapy of central nervous system defects; parkinson's, huntington's and alzheimers's diseases; antiischemic/ antiepileptic agents
09/21/1999US5955300 Immunoglobulin fusion protein with amino acid replacements immunosuppressant against autoimmune diseases; useful in the therapeutic treament of melanomas and leukemias
09/21/1999US5955299 For diagnosis and treatment of systemic lupus erythematosus; antisense agents
09/21/1999US5955292 Antibodies which bind to a polypeptide which can be used as a diagnostic tool to screen for cell propagation disorders
09/21/1999US5955291 Antibodies against extrcellular domain; useful as a diagnostic tool of tumor formation; monitoring of wound healing; imaging agents
09/21/1999US5955288 Screening for ligands by transforming yeast cells which constitutively express heterologous kinase with complementary dna library, detecting intracellular protein kinase activity
09/21/1999US5955284 Screening for serine protease inhibitors by using; hybridization detecting complex
09/21/1999US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases
09/21/1999US5955282 Human galactosyltransferases
09/21/1999US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents
09/21/1999US5955260 Antibodies that bind viral proteins that share homogeneity; for diagnostic immunoassay of virus in sample
09/21/1999US5955256 Mixing with photosensitizer and blocking agent of cysteine, n-acetylcysteine, dithiothreitol, butylated hydroxytoluene, butylated hydroxyanisole, tyrosine, histidine, tryptophan, propyl gallate, or mercaptopropionyl glycine
09/21/1999US5955122 Method of improving efficiency in ruminants
09/21/1999US5955100 Prodrugs their preparation and use as pharmaceuticals
09/21/1999US5955078 Novel polypeptides and monoclonal antibodies, preparation and use to combat infection at the site of wounds, surgical implants and other in-dwelling devices such as catheters
09/21/1999US5955076 Immunoactive peptides and antibodies and their use in anti-allergy treatment
09/21/1999US5955075 Molecular hybridization, genetic engineering
09/21/1999US5955074 Directed human immune globulin for the prevention and treatment of staphylococcal infections
09/21/1999US5955072 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
09/21/1999US5955069 Use of canine interferon-γ(IFN-γ) to treat non-atopic dermatitis
09/21/1999US5955055 Detection accumulated peptide with amino acid sequence region of apolipoprotein or elastin; labelling; diagnosing atherosclerosis
09/21/1999US5954706 Drug delivery
09/21/1999CA2194960C Cleavage of 5.alpha.-reductase mrna
09/21/1999CA2179286C Broad spectrum antimicrobial compounds and methods of use
09/21/1999CA2174971C Neural axon outgrowth modulators
09/21/1999CA2145313C Antimicrobial peptides
09/21/1999CA2098773C Recombinant coccidia and its use in a vaccine
09/21/1999CA2073741C Thromboplastin extract, reagent, and preparation thereof
09/21/1999CA2045761C Ws7622a mono- or di- sulfate, process for preparation thereof and use thereof
09/21/1999CA2016841C A method for producing polymers having a preselected activity
09/21/1999CA2012867C Novel cytotoxic cyclic depsipeptides from the tunicate trididemnum solidum
09/21/1999CA2006087C Polypeptides isolated from the venom of the spider hololena curta
09/21/1999CA1340761C Interleukin-4-receptors
09/20/1999CA2232812A1 Interleukin-1 receptor antagonist beta (il-1ra.beta.)
09/16/1999WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses
09/16/1999WO1999046390A1 Chitinase chitin-binding fragments
09/16/1999WO1999046389A1 Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
09/16/1999WO1999046388A1 Nucleic acid enzyme showing allosteric rna-cleaving activity on target rna
09/16/1999WO1999046386A1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5
09/16/1999WO1999046385A2 Compositions and methods for the treatment and prevention of metastatic disorders
09/16/1999WO1999046383A1 Human n-type calcium channel isoform and uses thereof
09/16/1999WO1999046381A2 Human fgf gene and gene expression products
09/16/1999WO1999046380A2 Human membrane spanning proteins
09/16/1999WO1999046379A2 Human receptor proteins; related reagents and methods
09/16/1999WO1999046378A1 Novel g protein-coupled receptor proteins
09/16/1999WO1999046377A2 A human vanilloid receptor-like cation channel
09/16/1999WO1999046375A2 Human nucleic acid sequences from prostate tissue
09/16/1999WO1999046374A2 Human nucleic acid sequences from prostate tumour tissue
09/16/1999WO1999046372A2 Ribozymes capable of inhibiting the expression of the ccr5 receptor